See more : Webjet Limited (WEBJF) Income Statement Analysis – Financial Results
Complete financial analysis of Guangdong Marubi Biotechnology Co., Ltd. (603983.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Guangdong Marubi Biotechnology Co., Ltd., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Home Reit Plc (HOME.L) Income Statement Analysis – Financial Results
- K.C.P. Sugar and Industries Corporation Limited (KCPSUGIND.BO) Income Statement Analysis – Financial Results
- ATI Inc. (ATD.DE) Income Statement Analysis – Financial Results
- Aurum PropTech Limited (AURUM.NS) Income Statement Analysis – Financial Results
- iHuman Inc. (IH) Income Statement Analysis – Financial Results
Guangdong Marubi Biotechnology Co., Ltd. (603983.SS)
About Guangdong Marubi Biotechnology Co., Ltd.
Guangdong Marubi Biotechnology Co., Ltd. provides eye care product in China. It engages in the research and development, design, production, and sales of various cosmetic products based on skin science and biological science research. The company offers its products under the Marumi, Chunji, and Lianhuo brand names. Guangdong Marubi Biotechnology Co., Ltd. was founded in 2002 and is based in Guangzhou, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.23B | 1.73B | 1.79B | 1.74B | 1.80B | 1.58B | 1.35B | 1.21B | 1.19B | 1.08B | 973.74M | 814.91M | 613.18M |
| Cost of Revenue | 652.22M | 547.29M | 643.04M | 589.75M | 573.46M | 498.96M | 429.01M | 390.58M | 373.38M | 270.16M | 231.77M | 206.56M | 132.43M |
| Gross Profit | 1.57B | 1.18B | 1.14B | 1.16B | 1.23B | 1.08B | 923.31M | 817.54M | 817.85M | 805.35M | 741.97M | 608.36M | 480.76M |
| Gross Profit Ratio | 70.69% | 68.40% | 64.02% | 66.20% | 68.16% | 68.34% | 68.28% | 67.67% | 68.66% | 74.88% | 76.20% | 74.65% | 78.40% |
| Research & Development | 62.29M | 52.93M | 50.49M | 50.15M | 44.87M | 33.82M | 28.30M | 24.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 42.31M | 42.53M | 39.82M | 33.35M | 45.10M | 28.06M | 29.57M | 21.79M | 84.33M | 87.19M | 60.88M | 41.89M | 32.53M |
| Selling & Marketing | 1.11B | 846.16M | 741.29M | 564.10M | 540.45M | 534.59M | 466.95M | 472.28M | 419.75M | 404.86M | 423.49M | 345.97M | 240.34M |
| SG&A | 1.15B | 888.69M | 781.12M | 597.45M | 585.55M | 562.65M | 496.52M | 494.06M | 504.08M | 492.05M | 484.37M | 387.87M | 272.87M |
| Other Expenses | 43.89M | 69.36M | 62.12M | 20.15M | 25.53M | 2.13M | 589.55K | 13.20M | 16.39M | 12.64M | 10.88M | 7.84M | -1.59M |
| Operating Expenses | 1.24B | 1.01B | 893.73M | 667.76M | 655.95M | 622.07M | 575.01M | 571.78M | 519.56M | 506.37M | 497.45M | 399.01M | 282.43M |
| Cost & Expenses | 1.91B | 1.56B | 1.54B | 1.26B | 1.23B | 1.12B | 1.00B | 962.37M | 892.94M | 776.53M | 729.21M | 605.57M | 414.86M |
| Interest Income | 21.41M | 16.11M | 35.47M | 51.21M | 22.50M | 7.89M | 12.45M | 16.72M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 5.93M | 3.24M | 1.02M | 1.13M | 299.12K | 7.43M | 222.92K | 119.11K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 25.69M | 37.35M | 33.40M | 21.34M | 24.95M | 22.66M | 8.43M | 8.93M | 13.70M | 9.28M | 2.46M | 2.15M | 1.44M |
| EBITDA | 354.54M | 248.83M | 345.55M | 581.15M | 638.97M | 508.83M | 375.07M | 282.44M | 298.44M | 298.98M | 246.98M | 211.50M | 199.76M |
| EBITDA Ratio | 15.93% | 14.01% | 19.17% | 33.79% | 35.41% | 29.99% | 27.35% | 21.69% | 25.05% | 27.80% | 25.62% | 25.97% | 32.56% |
| Operating Income | 319.34M | 207.34M | 298.99M | 572.52M | 612.65M | 484.17M | 366.05M | 260.31M | 313.67M | 306.14M | 249.80M | 212.80M | 201.45M |
| Operating Income Ratio | 14.35% | 11.97% | 16.73% | 32.81% | 34.02% | 30.73% | 27.07% | 21.55% | 26.33% | 28.46% | 25.65% | 26.11% | 32.85% |
| Total Other Income/Expenses | -2.25M | -755.25K | 10.63M | -5.16M | 1.37M | 2.13M | 589.55K | 13.20M | 16.39M | 12.63M | 8.52M | 7.84M | -1.60M |
| Income Before Tax | 317.09M | 206.58M | 309.63M | 567.37M | 614.02M | 486.30M | 366.64M | 273.51M | 330.06M | 318.78M | 258.32M | 220.64M | 199.85M |
| Income Before Tax Ratio | 14.25% | 11.93% | 17.33% | 32.51% | 34.10% | 30.86% | 27.11% | 22.64% | 27.71% | 29.64% | 26.53% | 27.08% | 32.59% |
| Income Tax Expense | 39.50M | 39.15M | 68.43M | 103.97M | 101.20M | 74.26M | 54.73M | 41.32M | 48.62M | 47.40M | 39.70M | 33.78M | 32.59M |
| Net Income | 259.42M | 174.18M | 247.92M | 464.40M | 514.89M | 415.28M | 311.92M | 232.19M | 281.43M | 271.37M | 218.61M | 186.88M | 167.26M |
| Net Income Ratio | 11.66% | 10.06% | 13.87% | 26.61% | 28.59% | 26.35% | 23.07% | 19.22% | 23.63% | 25.23% | 22.45% | 22.93% | 27.28% |
| EPS | 0.65 | 0.43 | 0.62 | 1.16 | 1.28 | 1.15 | 0.87 | 0.64 | 0.78 | 0.75 | 0.61 | 1.04 | 5.58 |
| EPS Diluted | 0.65 | 0.43 | 0.62 | 1.16 | 1.28 | 1.15 | 0.87 | 0.64 | 0.78 | 0.75 | 0.61 | 1.04 | 5.58 |
| Weighted Avg Shares Out | 399.10M | 401.00M | 401.00M | 401.00M | 401.00M | 361.11M | 358.53M | 362.80M | 360.81M | 361.83M | 358.38M | 179.69M | 401.82M |
| Weighted Avg Shares Out (Dil) | 399.10M | 401.00M | 401.00M | 401.00M | 401.00M | 361.11M | 358.53M | 362.80M | 360.81M | 361.83M | 358.38M | 179.69M | 401.82M |
Source: https://incomestatements.info
Category: Stock Reports